Jan 05, 2021
Immutep Completes Recruitment of Head and Neck Cancer Patients of Phase II TACTI-002 Study
Dec 28, 2020
Immutep Secures United States Patent For Eftilagimod Alpha In Combination With A PD-1 Pathway Inhibitor
Dec 16, 2020
Immutep Upscales Efti Manufacturing
Dec 15, 2020
Immutep Operational Update
Dec 08, 2020
Immutep’s Chinese Partner EOC Pharma to Start Phase II Metastatic Breast Cancer Study
